Navigation Links
Small Amounts of Dark Chocolate May Guard Against Heart Failure
Date:8/17/2010

y increased by 23 percent.

"Chocolate is still very calorie-dense, and there's fat and sugar that comes along with it, so moderation is a very important part of the story," Mittleman said.

Chocolate in Sweden is held to different quality standards than in the United States, but there are still characteristics you should look for when choosing chocolate, Mittleman said.

The chocolate measured in this study was mostly high-quality dark chocolate without a lot of added sugar, though it was commercially available, he said.

And the higher the cocoa content, the better. The cocoa content of the chocolate consumed by the women in this study was about 30 percent whereas, in the United States, dark chocolate is only required to contain 15 percent cocoa solids.

And 20 to 30 grams would be about half-to-two-thirds of an average American candy bar, Mittleman said.

The heart benefit of dark chocolate could be the result of any number of factors, including more flavonoids, or antioxidants, that can smooth heart function.

"It would make sense that having a higher intake of flavonoid-containing foods to reduce blood pressure would have a positive effect," said Dr. Eugene Storozynsky, an assistant professor in the heart failure transplant unit at the University of of Rochester Medical School.

Mittleman said there's no reason that the benefits of chocolate wouldn't extend to men as well, but this still needs to be confirmed.

Linda Van Horn, immediate past chair of the American Heart Association's Nutrition Committee and professor in the department of preventive medicine at Northwestern University's Feinberg School of Medicine in Chicago, said people shouldn't misinterpret the study findings as a carte blanche to satisfy their sweet tooth.

"This is not an 'eat all you want' take-home message; rather it's that eating a little dark chocolate can be healthful, as long as other adverse behaviors do not occur, such as weight ga
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
2. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
3. Small Increase in Diabetes Risk Noted in Statin Patients
4. Small to Mid-Sized Hospitals Turn to Orion Health to Implement Health IT Solutions for Improved Patient Care and Outcomes
5. Media, small businesses invited to ACS Webinar on ways to take advantage of Chinas dynamic growth
6. Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program
7. Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement Gained
8. Small Dogs Traced Back to Middle Eastern Wolf
9. Landrieu Comments on Presidents Small Business Health Care Report
10. Small molecule with high impact
11. A Small Grass-roots Non-profit, Announces That They Haven't Gone Away and are Still Alive with Helping the Disadvantaged Children in Ukraine
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Small Amounts of Dark Chocolate May Guard Against Heart Failure
(Date:5/26/2015)... San Diego, CA (PRWEB) May 26, 2015 ... medical director, launched and directed a hospital-wide Patient Blood ... in Bangor that reduced overall blood usage by more ... five-year period. , Covered in detail in an ... PBM program resulted in substantially reduced perioperative red cell ...
(Date:5/26/2015)... CO (PRWEB) May 26, 2015 It ... diverse community foundation in Colorado. On Wednesday, May 13, ... ushered in a new era of community-based giving with ... Titled “Our Future in the Making,” the event celebrated ... The Denver Foundation to mobilize resources for good. , ...
(Date:5/26/2015)... Relias Learning , the leader in online ... services market, announces expansion of their user group sessions ... participation in 2014, they will double the number of ... an exciting new facelift. , Regional user group ... best practices, share their expertise, provide feedback directly to ...
(Date:5/26/2015)... 26, 2015 CIO Review has chosen ... Pharma and Life Sciences Technology Solution Providers. The positioning is ... compliant solution which is applicable across the entire security spectrum ... for broad adoption. , “SIGNiX has been on our ... Pharma and Life Sciences Technology space, and we are happy ...
(Date:5/26/2015)... Indosoft, Inc ., developer of ... DMi Partners contact center to Q-Suite 5.8 call ... contact center ACD system to drop Asterisk 1.4 support. ... trunk features as diversion headers, added Lyra support via ... to warm transfers to improve information handling ...
Breaking Medicine News(10 mins):Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3
... , CRANBURY, N.J., Sept. 10 Amicus ... and chief executive officer, John F. Crowley, will be presenting at the ... scheduled to begin on Monday, September 14 at 5:05 p.m. EDT. , ... the presentation by logging on to the Investors section of the Amicus ...
... Sept. 10 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... global life sciences markets, today reported financial results for the three-month ... million, a net loss of $62 million and a loss per ... $252 million in total revenue, a net loss of $10 million ...
... , , CAMBRIDGE, ... ISIS ) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ... Office (USPTO) has allowed an Isis patent application that further expands ... patent broadly covers methods of cleaving a target RNA via a ...
... , , , ST. ... ) announced that Novation, the leading health care supply contracting ... systems to its capital products contract portfolio. This is ... robotic interventional technology among Novation,s capital products offerings. This ...
... , SAN DIEGO, Sept. 10 The American ... to educate individuals and couples about their family-building options in a ... 21st. Those who attend Dessert & Learn La Jolla ... Law, about third party reproduction options like egg donation, sperm donation, ...
... (OTCBB: GVBP.OB) - GENova Biotherapeutics, Inc., ("GENova"), a biotechnology ... that disrupt the advance of life-threatening diseases, today announced ... drug target that combats breast cancer. , The target, ... death in breast cancer cells, thus curtailing development of ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2009 Financial Results 2Health News:MDS Reports Third Quarter 2009 Financial Results 3Health News:MDS Reports Third Quarter 2009 Financial Results 4Health News:MDS Reports Third Quarter 2009 Financial Results 5Health News:MDS Reports Third Quarter 2009 Financial Results 6Health News:MDS Reports Third Quarter 2009 Financial Results 7Health News:MDS Reports Third Quarter 2009 Financial Results 8Health News:MDS Reports Third Quarter 2009 Financial Results 9Health News:MDS Reports Third Quarter 2009 Financial Results 10Health News:MDS Reports Third Quarter 2009 Financial Results 11Health News:MDS Reports Third Quarter 2009 Financial Results 12Health News:MDS Reports Third Quarter 2009 Financial Results 13Health News:MDS Reports Third Quarter 2009 Financial Results 14Health News:MDS Reports Third Quarter 2009 Financial Results 15Health News:MDS Reports Third Quarter 2009 Financial Results 16Health News:MDS Reports Third Quarter 2009 Financial Results 17Health News:MDS Reports Third Quarter 2009 Financial Results 18Health News:MDS Reports Third Quarter 2009 Financial Results 19Health News:MDS Reports Third Quarter 2009 Financial Results 20Health News:MDS Reports Third Quarter 2009 Financial Results 21Health News:MDS Reports Third Quarter 2009 Financial Results 22Health News:MDS Reports Third Quarter 2009 Financial Results 23Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 2Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 3Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 4Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 5Health News:Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology 6Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 2Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 3Health News:Stereotaxis Awarded Exclusive Contract by Novation for Robotic Interventional Technology 4Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 2Health News:Innovative Program Educates Hopeful Parents on Third Party Reproduction 3Health News:GENova files patent for new breast cancer treatment 2
(Date:5/26/2015)... May 26, 2015 Boston Scientific Corporation (NYSE: ... 36 th Annual Global Healthcare Conference on June 9 ... Dan Brennan , executive vice president and chief ... Relations, will participate in a 35-minute question and answer session ... 10 a.m. PT. A live webcast of the ...
(Date:5/26/2015)... 2015 Xencor, Inc. (NASDAQ: XNCR ), ... the treatment of autoimmune diseases, asthma and allergic diseases, ... President and Chief Executive Officer, will present at the ... at 8:30 a.m. ET in New York ... of the presentation will be available on the "Events ...
(Date:5/26/2015)... 26, 2015  Northstar Global Business Services, Inc. ... a deal with Mr. Checkout, a national distribution ... product, SNORenz to brick and mortar retail stores. ... cross section of about fifty convenience stores, pharmacies, ... valuable statistics during the lead time the company ...
Breaking Medicine Technology:Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2Xencor to Present at Jefferies 2015 Healthcare Conference 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 3
... Nev., June 6, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... for: The 2.00% Convertible Senior Notes due February ... 2.875% Convertible Senior Notes due February 15, 2015 (the 2015 Notes), ... due May 1, 2015 (the May 2015 Notes), effective June 6, ...
... 2011 Sanofi (EURONEXT: SAN and NYSE: ... REGN ) today announced that data showing that the ... significantly improved survival in previously treated metastatic colorectal cancer ... on Gastrointestinal Cancer on June 25, 2011.  The abstract ...
Cached Medicine Technology:PDL BioPharma Announces Conversion Rate Adjustments for its Convertible Notes 2ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 2ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 3ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 4ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 5ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 6ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients 7
Inquire...
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: